HANNAH LANCTOT: Open Payments
NPI 1437789534 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 25 payments from 13 companies in 2025. Trend: 2023 $817 · 2024 $565 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $165 |
| Alnylam Pharmaceuticals Inc. | 3 | $63 |
| Edwards Lifesciences Corporation | 1 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Amgen Inc. | 2 | $28 |
| Novo Nordisk Inc | 1 | $23 |
| HEARTFLOW, INC. | 1 | $20 |
| BridgeBio Pharma, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: JARDIANCE, ONPATTRO, LEQVIO, REPATHA, Wegovy, WAINUA, FFRct, Attruby.
Industry payments across PA — which companies pay providers there.
